We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Nordic American Tanker
NAT
$1.37B
| $1.26M | ﹤0.01% |
318,255
+11,776
| +4% | +$42.2K |
|
2027
Central Garden & Pet Co
CENT
$2.8B
| $1.26M | ﹤0.01% |
38,310
+1,686
| +5% | +$54.6K |
|
2028
Invesco Mortgage Capital
IVR
$805M
| $1.25M | ﹤0.01% |
113,177
+1,420
| +1% | +$18.3K |
|
2029
UFP Technologies
UFPT
$2.43B
| $1.25M | ﹤0.01% |
9,611
+877
| +10% | +$102K |
|
2030
Biohaven
BHVN
$2.21B
| $1.25M | ﹤0.01% |
91,191
+11,769
| +15% | +$187K |
|
|
AGNT
2031
AGNT Inc
AGNT
$734M
| $1.24M | ﹤0.01% |
97,938
+2,645
| +3% | +$35.3K |
|
2032
Geron
GERN
$949M
| $1.24M | ﹤0.01% |
572,637
+64,432
| +13% | +$183K |
|
2033
Comtech Telecommunications
CMTL
$51.8M
| $1.24M | ﹤0.01% |
99,516
+3,841
| +4% | +$55K |
|
2034
Twist Bioscience
TWST
$7.25B
| $1.24M | ﹤0.01% |
81,989
+1,472
| +2% | +$32.5K |
|
|
IMGN
2035
DELISTED
Immunogen Inc
IMGN
| $1.23M | ﹤0.01% |
320,502
-2,046
| -0.6% | -$8.72K |
|
2036
Clean Energy Fuels
CLNE
$346M
| $1.23M | ﹤0.01% |
282,161
-9,117
| -3% | -$47.1K |
|
|
FORG
2037
DELISTED
ForgeRock, Inc.
FORG
| $1.22M | ﹤0.01% |
59,343
+9,447
| +19% | +$192K |
|
2038
Bally's
BALY
$658M
| $1.22M | ﹤0.01% |
62,328
+1,539
| +3% | +$30.2K |
|
2039
Oscar Health
OSCR
$8.61B
| $1.22M | ﹤0.01% |
185,755
+11,678
| +7% | +$47.7K |
|
2040
Treace Medical Concepts
TMCI
$309M
| $1.21M | ﹤0.01% |
48,157
+5,386
| +13% | +$126K |
|
|
UMH
2041
UMH Properties
UMH
$1.36B
| $1.2M | ﹤0.01% |
81,376
+4,796
| +6% | +$78.8K |
|
2042
Ginkgo Bioworks
DNA
$521M
| $1.2M | ﹤0.01% |
22,619
+1,425
| +7% | +$90.3K |
|
|
CUTR
2043
DELISTED
Cutera, Inc.
CUTR
| $1.2M | ﹤0.01% |
50,875
+2,633
| +5% | +$84.2K |
|
2044
Keros Therapeutics
KROS
$221M
| $1.2M | ﹤0.01% |
28,091
+1,707
| +6% | +$86.2K |
|
2045
Outset Medical
OM
$90.8M
| $1.2M | ﹤0.01% |
4,337
+161
| +4% | +$59.1K |
|
|
DCPH
2046
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.19M | ﹤0.01% |
77,256
+9,830
| +15% | +$164K |
|
2047
Gulfport Energy Corp
GPOR
$2.88B
| $1.19M | ﹤0.01% |
14,886
+205
| +1% | +$14.9K |
|
|
HAPN
2048
Happen Inc
HAPN
$2.24B
| $1.19M | ﹤0.01% |
164,863
+8,288
| +5% | +$73.8K |
|
|
PFC
2049
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.19M | ﹤0.01% |
57,251
+1,162
| +2% | +$28.4K |
|
|
SCS
2050
DELISTED
Steelcase
SCS
| $1.18M | ﹤0.01% |
140,445
+5,676
| +4% | +$43.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.